Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BNKL - Bionik Laboratories Corp


N/A
0   0%

Share volume: 0
Last Updated: Fri 30 Aug 2024 11:00:11 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
-61.54%
2 Year
-65.52%
Key data
Stock price
N/A
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.03 - $0.50
52 WEEK CHANGE
-$0.62
MARKET CAP 
1.248 M
YIELD 
N/A
SHARES OUTSTANDING 
12.480 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website:
Employees: 44
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

bionik laboratories (otcqx: bnkl) is a pioneering medical device and robotics company developing transformational robotic rehabilitation technologies for individuals with neurological disorders. the company is dedicated to provide individuals with restricted mobility an improvement in overall health, comfort, accessibility, and quality of life through the commercialization of its proprietary products. the company’s lead program, arke™ is the most comprehensive lower-body exoskeleton that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking and other motion. currently in clinical development, arke will initially be used in a rehabilitation environment, with the goal of being made available for home use.

Recent news